Top asthma stories of 2023
Click Here to Manage Email Alerts
This year’s asthma research covered a broad variety of topics, such as the effect of the family dog’s fur on long-term outcomes, asthma care in prison, fast food restaurants and the Canadian wildfires.
Studies also continued to explore the impacts of asthma therapy, including biologics and corticosteroids. Check out Healio’s most popular asthma news for 2023 below.
Dog ownership in infancy may overcome genetic predisposition for wheeze, asthma
Patients with the rs2305480 variant of the GSDMB gene who had a pet dog as a baby did not have an increased risk for persistent wheeze or asthma, according to a study published in The Journal of Allergy and Clinical Immunology. Also, Frédéric de Blay, MD, shares his Perspective. Read more.
Season of birth may be associated with risk for adult-onset asthma
People born between January and June in Finland experienced a higher risk for adult-onset asthma than people born later in the year, researchers from Helsinki University Hospital reported in Asthma. Also, Christopher O’Brien, MD, PhD, FCCP, and Mark Corbett, MD, share their Perspectives. Read more.
Asthma, other chronic conditions undertreated among incarcerated individuals
Incarcerated individuals account for 0.85% of the total population in the United States but only 0.15% of asthma prescriptions, Jill Curran, MS, of Johns Hopkins Bloomberg School of Public Health, told Healio, with a 5.45-fold magnitude of difference between disease burden and treatment. Read more.
Cannabis use may increase mortality, morbidity from acute asthma exacerbations
Patients with asthma who used cannabis had increased risks for mortality, mechanical ventilation and altered mental status, according to a study of 406,800 patients presented at the CHEST Annual Meeting in Honolulu. Read more.
FDA approves Tezspire prefilled pen for self-administered asthma treatment
The government agency approved tezepelumab-ekko (Tezspire; Amgen, AstraZeneca) for self-administration in a prefilled, single-use pen for patients aged 12 years and older with severe asthma, according to a press release. Read more.
Children with asthma who live near fast-food restaurants have lower lung function changes
Children with asthma who lived within 500 meters of a fast-food restaurant had smaller changes in lung function during an intervention, even after researchers controlled for nearby roadways and BMI, Franziska Rosser, MD, MPH, ATSF, of University of Pittsburgh School of Medicine, said during the American Thoracic Society International Conference. Read more.
Triple therapy improves asthma outcomes compared with pairs of medications
The use of an inhaled corticosteroid, long-acting beta 2 agonist and long-acting muscarinic antagonist improved asthma outcomes compared with use of just two of those medications, researchers from University of Ioannina wrote in Respiratory Medicine. Read more.
Oral inhaled corticosteroids impose multiple burdens on quality of life in asthma
Burdensome events such as pneumonia, hoarse voice and oral thrush did not lead patients to halt asthma therapy, Vickram Tejwani, MD, of Cleveland Clinic Lerner College of Medicine/Case Western University School of Medicine, and colleagues found, but social stigma and psychosocial burdens may limit treatment adherence. Read more.
ED visits for asthma increase in New York City during Canadian wildfires
Particulate matter pollution at the 2.5 µg scale and ED visits for asthma in New York City both peaked on June 7, when smoke from wildfires in Canada spread throughout the Big Apple, according to George Thurston, ScD, of NYU Langone, and colleagues. Also, Albert Rizzo, MD, FACP, shares his Perspective. Read more.
Infant exposure to acid-suppressive medications linked to modest asthma risk
Although there was no association between prenatal exposure to acid-suppressive medications and risk for pediatric allergic diseases, exposures during infancy did present a modest risk for asthma, researchers wrote in JAMA Pediatrics. Read more.